| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-12 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 8e-06 |